In the first randomized trial of its kind, researchers found that adding chemoradiation to adjuvant chemotherapy did not ...

Adding pamrevlumab to standard chemotherapy did not improve survival in patients with locally advanced pancreatic cancer ...

Patients who had positive ctDNA tests after surgery were almost twice as likely to be alive at 3 years if they received ...

Chemotherapy has been known to cause damage to peripheral nerves, and sometimes the pain is chronic and severe enough that chemotherapy doses are reduced or discontinued. But prior research has not ...

Roche’s PATHWAY HER2 (4B5) test helps identify patients with HER2-ultralow breast cancer, who may be eligible for targeted ...

"Good Morning America" co-anchor Michael Strahan and his daughter Isabella Strahan open up about her cancer diagnosis in a ...

Among patients with resected gallbladder cancer, the addition of chemoradiation to chemotherapy treatment did not improve ...

Kate Middleton—who recently announced she's in remission after finishing cancer treatments—flew under the radar as she did ...

Patients with metastatic colorectal cancer (mCRC) harboring BRAF V600E mutations benefited from first-line treatment with the ...

Patients with metastatic colorectal cancer (mCRC) harboring BRAF V600E mutations benefited from first-line treatment with the targeted therapies encorafenib and cetuximab plus a mFOLFOX6 chemotherapy ...

Filling your fridge and pantry with a variety of foods before treatment begins and being flexible about your daily diet are ...

The FDA has approved a new treatment for patients with a common form of breast cancer that has spread to other parts of the ...